Research continues into optimizing dosing protocols for different patient populations, including those with specific metabolic conditions
Spending and eating less and differently Among US consumers surveyed by PwC, GLP-1 users spent an average of about 11% less on most categories of food, with the largest reductions in sweet and salty snacks and baked foods
If kidney function declines, dose reduction or discontinuation may be necessary
We offer transparent pricing with no hidden fees
Peer review Peer review information Nature Chemistry thanks Jiajia Dong, Seiya Kitamura and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Regardless of if youre someone looking to try these alternatives or just curious about the developing GLP-1 market in general, I hope this article gave you a little insight into the future of weight loss drugs and supplements.